ZhangW,MaZ,LiW,LiG,ChenL,LiuZ, 2015.Discovery of quinazoline-based fluorescent probes to α1-adrenergic receptors,ACS Med Chem Lett 6 502 -6
GratzkeC,BachmannA,DescazeaudA,DrakeMJ,MadersbacherS,MamoulakisC, 2015.EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction,Eur Urol 67 1099 -109
AustinPF,BauerSB,BowerW,ChaseJ,FrancoI,HoebekeP,RittigS,WalleJV,von GontardA,WrightA,YangSS, 2016.The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society, 35 471 -81
PhilipsG., 2015.Diseases of the Prostate, -
BaglaS,MartinCP,van BredaA,SheridanMJ,SterlingKM,PapadourisD, 2014.Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia,J Vasc Interv Radiol 25 47 -52
VeeratterapillayR,PickardR,HardingC, 2014.The role of uroflowmetry in the assessment and management of men with lower urinary tract symptoms-revisiting the evidence,J Clin Urol 7 154 -8
ChoMK,NohEJ,KimCH, 2017.Accuracy and precision of a new portable ultrasound scanner, the Biocon700, in residual urine volume measurement,International urogynecology journal 28 1057 -61
PesceF,RubilottaE,RighettiR,DAmico,A , Frigo,M , Martinelli,N, 2002.Results in 522 patients assessed in a" flow-clinic",Urodinamica 12 154 -155
ScherHI,LeibelS,FuksZ,Cordon-CardoC, 2015.Cancer of the prostate,Rosenberg's Cancer Principles and Practices of Oncology 932 -80
KullmannFA,BirderLA,AnderssonK, 2015.Translational research and functional changes in voiding function in older adults,Clin Geriatr Med 31 535 -48
HricakH,ChoykePL,EberhardtSC,LeibelSA,ScardinoPT, 2007.Imaging prostate cancer: a multidisciplinary perspective,Radiology 243 28 -53
FüttererJJ,HeijminkSW,SpermonJR, 2008.Imaging the male reproductive tract: current trends and future directions,Radiologic Clinics of North America 46 133 -47
ScherrDS,EasthamJ,OhoriM,ScardinoPT, 2012.Prostate biopsy techniques and indications: when, where, 20 18 -31
MeyerF,FradetY, 1998.,Prostate cancer: 4. Screening. CMAJ: Canadian Medical Association Journal 159 968 -72
SmithRA,CokkinidesV,BrawleyOW, 2009.a cancer journal for clinicians, 59 27 -41
WatanabeH,IgariD,TanahasiY,HaradaK,SaitohM. Development, 1974.and application of new equipment for transrectal ultrasonography,J Clin Ultrasound 2 91 -8
WatanabeH. History, 1989.and applications of transrectal sonography of the prostate,Urol Clin North Am 16 617 -22
LittrupPJ,BaileySE, 2000.Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management,Radiol Clin North Am 38 87 -113
MitterbergerM,PinggeraGM,PallweinL,GradlJ,FrauscherF,BartschG,StrasserH,AkkadT,HorningerW., 2007.The value of three‐dimensional transrectal ultrasonography in staging prostate cancer,BJU Int 100 47 -50
PallweinL,MitterbergerM,PelzerA,BartschG,StrasserH,PinggeraGM,AignerF,GradlJ,Zur NeddenD, 2008.Ultrasound of prostate cancer: recent advances,European radiology 18 707 -15
SajadiKP,TerrisMK,HamiltonRJ,CullenJ,AmlingCL,KaneCJ,Presti JrJC,AronsonWJ,FreedlandSJ, 2007.Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy,J Urol 178 990 -5
BarryMJ,CockettAT,HoltgreweHL,McConnellJD,SihelnikSA,WinfieldHN, 1993.Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia,J. Urol 150 351 -8
AgrawalCS,ChalisePR,BhandariBB, 2012.Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia,Nepal Med Coll J 10 104 -7
SinglaS,GargR,SinglaA,SharmaS,SinghJ,SethiP, 2014.Experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia,Journal of clinical and diagnostic research: JCDR 8 1 -3
UdehEI,OzoemenaOF,OgwucheE., 2012.The relationship between prostate volume and international prostate symptom score in Africans with benign prostatic hyperplasia,Niger J Med 21 290 -5
El DinKE,KiemeneyLA,De WildtMJ,DebruyneFM, 1996.Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score, 48 393 -7
RosetteJJ,AlivizatosG,MadersbacherS,SanzCR,NordlingJ,EmbertonM. EAU, 2001.guidelines on benign prostatic hyperplasia,Eur Urol 40 256 -263
CaineM., 1986.The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy,J Urol 136 1 -4
EckhardtMD,van VenrooijGE,BoonTA, 2001.and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia,Urology 58 966 -71
RoehrbornCG, 2012.BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE,BJU Int 101 17 -21
TrumbeckasD,MilonasD,JievaltasM,MatjosaitisAJ,KinciusM,GrybasA,KopustinskasV, 2011.Importance of prostate volume and urinary flow rate in prediction of bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia,Central European journal of urology 64 75 -
ChuangFP,LeeSS,WuST,YuDS,ChenHI,ChangSY,SunGH, 2003.Change in International Prostate Symptom Score after transurethral prostatectomy in Taiwanese men with benign prostate hyperplasia: Use of these changes to predict the outcome,Archives of andrology 49 129 -37